Published in BMC Infect Dis on July 06, 2006
Host Genetic Susceptibility to Avian Influenza A/H5N1 | NCT01074736
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol (2007) 2.35
Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog (2009) 1.81
2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol (2010) 1.30
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine (2011) 1.12
Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses. Clin Dev Immunol (2011) 0.96
Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis. Clin Exp Med (2012) 0.91
Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp Mol Med (2015) 0.89
Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection. Hum Genet (2013) 0.86
The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect Dis (2007) 0.84
Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis. Hum Genet (2011) 0.81
Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection. BMC Infect Dis (2009) 0.78
Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study. BMC Infect Dis (2008) 0.78
Characterization of the equine 2'-5' oligoadenylate synthetase 1 (OAS1) and ribonuclease L (RNASEL) innate immunity genes. BMC Genomics (2007) 0.78
Genetic variation of the human α-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection. PLoS One (2011) 0.77
Contrasted patterns of variation and evolutionary convergence at the antiviral OAS1 gene in old world primates. Immunogenetics (2015) 0.76
IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese. PLoS One (2008) 0.76
The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines (2014) 0.75
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Treatment of SARS with human interferons. Lancet (2003) 3.10
A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A (2002) 2.65
Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J (1985) 2.47
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun (2003) 1.88
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol (1999) 1.62
Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J Virol (1998) 1.53
The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res (1999) 1.52
Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein. Immunol Cell Biol (2003) 1.47
Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology (1995) 1.34
Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha. J Infect Dis (2004) 1.24
Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun (2005) 1.21
Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet (2003) 1.11
Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. J Viral Hepat (2004) 1.11
Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro. Intervirology (2001) 1.07
The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. J Clin Virol (2004) 1.01
Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis (2004) 0.98
Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology (2004) 0.97
ACE1 polymorphism and progression of SARS. Biochem Biophys Res Commun (2004) 0.95
Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antivir Ther (2004) 0.94
WHO declares Beijing to be free of SARS. Lancet (2003) 0.93
[A case-control study on the risk factors of severe acute respiratory syndromes among health care workers]. Zhonghua Liu Xing Bing Xue Za Zhi (2004) 0.89
[Study on the epidemiology and measures for control on severe acute respiratory syndrome in Guangzhou city]. Zhonghua Liu Xing Bing Xue Za Zhi (2003) 0.88
Host and environment are key factors. J Epidemiol Community Health (2003) 0.85
Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment. Pharmacogenetics (2004) 0.80
[Study on the risk factors related to severe acute respiratory syndrome among close contactors in Beijing]. Zhonghua Liu Xing Bing Xue Za Zhi (2004) 0.79
SARS treatment. Interferon shows promise in monkeys. Science (2004) 0.78
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med (2012) 6.93
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop (2003) 6.64
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol (2005) 6.04
TLR3 deficiency in patients with herpes simplex encephalitis. Science (2007) 5.86
Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS (2005) 5.51
Assessing agricultural risks of climate change in the 21st century in a global gridded crop model intercomparison. Proc Natl Acad Sci U S A (2013) 5.43
Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest (2002) 4.97
PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev (2008) 4.83
Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med (2008) 4.60
Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril (2003) 4.58
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet (2013) 4.57
Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ (2002) 4.47
Herpes simplex virus encephalitis in human UNC-93B deficiency. Science (2006) 4.26
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet (2013) 4.16
A high-resolution assessment on global nitrogen flows in cropland. Proc Natl Acad Sci U S A (2010) 4.08
Comparison of the World Health Organization (WHO) Child Growth Standards and the National Center for Health Statistics/WHO international growth reference: implications for child health programmes. Public Health Nutr (2006) 3.84
Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol (2005) 3.82
The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest (2005) 3.56
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest (2007) 3.54
Uncovering intrinsic modular organization of spontaneous brain activity in humans. PLoS One (2009) 3.43
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A (2005) 3.37
Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications. Acta Trop (2003) 3.16
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology (2011) 3.08
High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril (2004) 3.08
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer. J Clin Oncol (2004) 3.02
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science (2010) 2.99
Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med (2004) 2.95
Seasonal patterns in monthly hemoglobin A1c values. Am J Epidemiol (2005) 2.93
Parcellation-dependent small-world brain functional networks: a resting-state fMRI study. Hum Brain Mapp (2009) 2.91
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril (2005) 2.90
Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One (2009) 2.87
Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer (2007) 2.85
Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. Genes Dev (2012) 2.83
Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis (2007) 2.83
Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis (2005) 2.80
Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol (2004) 2.77
Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med (2010) 2.70
MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev (2009) 2.67
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54
Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg (2003) 2.51
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One (2009) 2.49
Why are babies getting bigger? Temporal trends in fetal growth and its determinants. J Pediatr (2002) 2.47
Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity (2010) 2.47
Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J Biol Chem (2004) 2.46
Flavonoids: promising anticancer agents. Med Res Rev (2003) 2.43
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest (2010) 2.43
Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system. Structure (2012) 2.42
Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol (2005) 2.42
Spatial analysis of hemorrhagic fever with renal syndrome in China. BMC Infect Dis (2006) 2.42
Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron (2011) 2.42
Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. J Natl Cancer Inst (2009) 2.35
The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat Immunol (2009) 2.34
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr (2007) 2.32
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31
Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol (2002) 2.29
The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study. PLoS One (2008) 2.23
Landscape elements and Hantaan virus-related hemorrhagic fever with renal syndrome, People's Republic of China. Emerg Infect Dis (2007) 2.22
Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J Infect Dis (2005) 2.21
Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens (2009) 2.20
Models in the development of clinical practice guidelines. Ann Intern Med (2014) 2.18
Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J Clin Invest (2007) 2.17
Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity (2005) 2.16
Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci (2004) 2.14
Environmental factors contributing to the spread of H5N1 avian influenza in mainland China. PLoS One (2008) 2.14
Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials. J Neurosurg (2002) 2.12
Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras. AIDS (2004) 2.11
R gene-controlled host specificity in the legume-rhizobia symbiosis. Proc Natl Acad Sci U S A (2010) 2.10
Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors. Cancer Res (2005) 2.07
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med (2004) 2.06
Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother (2010) 2.02
Default mode network as revealed with multiple methods for resting-state functional MRI analysis. J Neurosci Methods (2008) 2.01
Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc Natl Acad Sci U S A (2002) 1.99
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem (2003) 1.97
Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96
Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics. J Neurotrauma (2005) 1.96
Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer (2005) 1.93
Impact of mobile radiographic screening on tuberculosis among drug users and homeless persons. Am J Respir Crit Care Med (2007) 1.93
Spatial analysis of malaria in Anhui province, China. Malar J (2008) 1.92
ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. J Clin Invest (2008) 1.92
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results. Sex Transm Dis (2006) 1.91
Clients of female sex workers in Nyanza province, Kenya: a core group in STD/HIV transmission. Sex Transm Dis (2002) 1.91
Risk factors for buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis (2007) 1.90
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89
High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. J Biol Chem (2002) 1.89
Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis (2010) 1.89
Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest (2011) 1.88
Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. AIDS (2007) 1.88
Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood (2012) 1.88
At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer (2009) 1.88
What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS (2002) 1.87